Education
About Us
Working with TipRanks
Follow Us
China Shineway Pharmaceutical Group Limited (HK:2877)
:2877
RESEARCH TOOLSreports
2877 Stock Chart & Stats
Day’s Range― - ―
52-Week RangeHK$6.96 - HK$10.76
Previous CloseN/A
Volume914.00K
Average Volume (3M)1.41M
Market Cap
HK$6.53B
Enterprise Value-HK$1.33B
Total Cash (Recent Filing)HK$6.49B
Total Debt (Recent Filing)HK$346.53M
Price to Earnings (P/E)7.3
Beta0.58
Next Earnings
Mar 31, 2026EPS EstimateN/A
Next Dividend Ex-Date
Sep 09, 2025Dividend Yield5.89%
Share Statistics
EPS (TTM)0.89
Shares Outstanding827,000,000
10 Day Avg. Volume1,778,500
30 Day Avg. Volume1,405,434
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
HK$8.50Price Target Upside-0.93% Downside
Rating ConsensusModerate Buy
Number of Analyst Covering0
China Shineway Pharmaceutical Group Limited News
2877 FAQ
What was China Shineway Pharmaceutical Group Limited’s price range in the past 12 months?
China Shineway Pharmaceutical Group Limited lowest stock price was HK$6.96 and its highest was HK$10.76 in the past 12 months.
What is China Shineway Pharmaceutical Group Limited’s market cap?
China Shineway Pharmaceutical Group Limited’s market cap is HK$6.53B.
When is China Shineway Pharmaceutical Group Limited’s upcoming earnings report date?
China Shineway Pharmaceutical Group Limited’s upcoming earnings report date is Mar 31, 2026 which is in 208 days.
How were China Shineway Pharmaceutical Group Limited’s earnings last quarter?
China Shineway Pharmaceutical Group Limited released its earnings results on Aug 27, 2025. The company reported HK$0.885 earnings per share for the quarter, beating the consensus estimate of N/A by HK$0.885.
Is China Shineway Pharmaceutical Group Limited overvalued?
According to Wall Street analysts China Shineway Pharmaceutical Group Limited’s price is currently Overvalued.
Does China Shineway Pharmaceutical Group Limited pay dividends?
China Shineway Pharmaceutical Group Limited pays a Semiannually dividend of HK$0.12 which represents an annual dividend yield of 5.89%. See more information on China Shineway Pharmaceutical Group Limited dividends here
What is China Shineway Pharmaceutical Group Limited’s EPS estimate?
China Shineway Pharmaceutical Group Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does China Shineway Pharmaceutical Group Limited have?
China Shineway Pharmaceutical Group Limited has 827,000,000 shares outstanding.
What happened to China Shineway Pharmaceutical Group Limited’s price movement after its last earnings report?
China Shineway Pharmaceutical Group Limited reported an EPS of HK$0.885 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 5.15%.
Which hedge fund is a major shareholder of China Shineway Pharmaceutical Group Limited?
Currently, no hedge funds are holding shares in HK:2877
China Shineway Pharmaceutical Group Limited Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
7.08%
12-Months-Change
Fundamentals
Return on Equity
10.85%
Trailing 12-Months
Asset Growth
7.15%
Trailing 12-Months
Company Description
China Shineway Pharmaceutical Group Limited
China Shineway Pharmaceutical Group Limited is a leading pharmaceutical company based in China, specializing in the development, manufacture, and sale of traditional Chinese medicine (TCM) and modern pharmaceuticals. The company operates primarily in the healthcare and pharmaceutical sectors, offering a wide range of products including Chinese patent medicine, soft capsules, granules, and injections. With a strong emphasis on innovation and quality, Shineway focuses on providing effective healthcare solutions to meet the diverse needs of its consumers.
Technical Analysis
China Traditional Chinese Medicine Holdings Co
―
Jilin Province Huinan Changlong Bio Pharmacy Co. Ltd. Class H
―
Pak Fah Yeow International Limited
―
Jacobson Pharma Corporation Limited
―
Shandong Xinhua Pharmaceutical Company Limited Class H
―
Ownership Overview
―
Insiders
1.83%
Mutual Funds
― Other Institutional Investors
96.34% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---